Landscapes / Companies
Viatris Innovation GmbH not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
Drugs
2
in active trials · 7 in all
Trials
5 active
24 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 31 Dec 2026Phase 3 trial completes | |||
| Next date | 31 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Lupus Erythematosus, Systemic, Nephritis, Lupus and 1 more | ||||
| Open drug page | |||||
Selatogrelnot checked |
— |
Phase 3 | Jul 2027Phase 3 trial completes | ||
| Next date | Jul 2027 · Phase 3 trial completes | ||||
| Also tested for | Acute Myocardial Infarction | ||||
| Open drug page | |||||
About
- No active trial
- 14C-Cenerimod, AC-076, Clopidogrel, Diltiazem ER, Rifampicin
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021